MedPath
FDA Product

Creon

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Creon

0032-1203

Regulatory Information

0032-1203

BLA020725

C73585

March 6, 2024

USA

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules , for oral use Initial U.S. Approval: 2009

HUMAN PRESCRIPTION DRUG LABEL

107

Company Information

AbbVie Inc.

078458370

Active Ingredients

PANCRELIPASE AMYLASE

Quantity: 15000 [USP'U] in 1 1

Code: YOJ58O116E

Class Code: ACTIB

PANCRELIPASE PROTEASE

Quantity: 9500 [USP'U] in 1 1

Code: 3560D81V50

Class Code: ACTIB

PANCRELIPASE LIPASE

Quantity: 3000 [USP'U] in 1 1

Code: 8MYC33932O

Class Code: ACTIB

CETYL ALCOHOL

Code: 936JST6JCN

Class Code: IACT

HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)

Code: G4U024CQK6

Class Code: IACT

DIMETHICONE

Code: 92RU3N3Y1O

Class Code: IACT

POLYETHYLENE GLYCOL, UNSPECIFIED

Code: 3WJQ0SDW1A

Class Code: IACT

TRIETHYL CITRATE

Code: 8Z96QXD6UM

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

HYPROMELLOSE, UNSPECIFIED

Code: 3NXW29V3WO

Class Code: IACT

CARRAGEENAN

Code: 5C69YCD2YJ

Class Code: IACT

POTASSIUM CHLORIDE

Code: 660YQ98I10

Class Code: IACT

Active Moieties

PANCRELIPASE AMYLASE

Code: YOJ58O116E

PANCRELIPASE LIPASE

Code: 8MYC33932O

PANCRELIPASE PROTEASE

Code: 3560D81V50

© Copyright 2025. All Rights Reserved by MedPath